constipation on pregnancy - Nursing Case Study

Pathophysiology

• Primary mechanism: Elevated progesterone levels during pregnancy lead to the relaxation of smooth muscle in the gastrointestinal tract, slowing peristalsis and resulting in delayed bowel transit time and constipation.

• Secondary mechanism: The growing uterus exerts pressure on the intestines, further slowing down bowel movement and contributing to the development of constipation.

• Key complication: Prolonged constipation can result in hemorrhoids due to increased straining during defecation, impacting maternal comfort and health.

Patient Profile

Demographics:

29 years old, female, school teacher

History:

• Key past medical history: No significant past medical history, currently 28 weeks pregnant

• Current medications: Prenatal vitamins, iron supplements

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Constipation for the past two weeks

• Key symptoms: Abdominal discomfort, bloating, infrequent bowel movements, mild nausea, hemorrhoids developing

• Vital signs: Blood pressure 140/90 mmHg, heart rate 95 bpm, respiratory rate 20 breaths per minute, temperature 98.6°F

Section 1

As the pregnancy progresses to 30 weeks, the patient returns to the clinic with worsening symptoms. She now reports increased abdominal pain and persistent bloating, alongside minimal relief from bowel movements despite dietary modifications and increased fluid intake. On physical examination, her abdomen is distended, and she exhibits tenderness upon palpation of the lower quadrants. The previously noted hemorrhoids have increased in size, causing significant discomfort. Her blood pressure remains elevated at 145/92 mmHg, and her heart rate is now 100 bpm, indicating a potential concern for gestational hypertension, which can exacerbate gastrointestinal symptoms.

New laboratory findings reveal a slightly elevated white blood cell count at 11,000/mm³, suggesting a possible inflammatory response, though her hemoglobin levels remain stable. Serum electrolytes show mild hypokalemia, likely due to inadequate dietary intake and the use of iron supplements that can contribute to constipation. In response to these findings, the healthcare team considers modifying her treatment plan to include a stool softener and possibly a change in her iron supplement to a formulation with less constipating effects. Additionally, they emphasize the importance of managing her blood pressure to prevent further complications.

Given these developments, the multidisciplinary team decides to monitor the patient closely, with a follow-up scheduled in one week to reassess her symptoms and blood pressure. They also educate the patient on the importance of maintaining an appropriate diet rich in fiber and potassium, encouraging regular physical activity to promote bowel motility. This approach aims to alleviate her constipation while addressing the new complication of elevated blood pressure, preventing further deterioration of her condition as the pregnancy progresses.

Section 2

The patient returns for her follow-up appointment after one week, and the clinical team conducts a thorough assessment to evaluate the effectiveness of the interventions implemented. During this visit, the patient reports a slight improvement in bowel movements, experiencing marginally less discomfort, although the abdominal bloating and pain persist. Her adherence to the recommended dietary modifications and increased physical activity is confirmed, yet the relief remains limited. On examination, her abdomen is still distended, with tenderness especially pronounced in the lower quadrants, indicating the ongoing presence of bowel obstruction symptoms. The hemorrhoids continue to cause significant discomfort, though the use of stool softeners appears to have mitigated some of the pain associated with bowel movements.

Vital signs reveal that her blood pressure has increased slightly to 148/94 mmHg, while her heart rate remains stable at 98 bpm. These findings suggest that while there has been a slight improvement in her gastrointestinal symptoms, the potential for gestational hypertension remains a concern. The patient’s latest laboratory results show a further elevation in her white blood cell count to 12,500/mm³, raising suspicion of an underlying inflammatory process that may be contributing to her symptoms. Her potassium levels have improved marginally, suggesting partial effectiveness of dietary adjustments, but the team is concerned about maintaining these improvements given her ongoing symptoms and elevated blood pressure.

In light of these findings, the healthcare team recognizes the need to adjust the treatment plan further. They discuss the possibility of introducing a more targeted approach to manage her blood pressure, potentially adding a low-dose antihypertensive medication that is safe during pregnancy. Additionally, they consider referring the patient to a specialist for further evaluation of her gastrointestinal symptoms, particularly to investigate potential causes of the persistent inflammation. The team emphasizes the importance of continued monitoring and reassessment, scheduling another follow-up within the next week to closely track her progress and adjust the management plan as needed.

Section 3

During the follow-up appointment, the healthcare team decides to introduce a low-dose antihypertensive medication, specifically labetalol, which is deemed safe for use during pregnancy. The team closely monitors the patient's response to this intervention, aiming to manage her slightly elevated blood pressure and reduce the risk of gestational hypertension. Over the next few days, the patient reports feeling somewhat better with a slight reduction in headache frequency, and her blood pressure readings have stabilized around 140/90 mmHg, suggesting a modest improvement.

However, new complications arise as the patient begins to experience intermittent episodes of mild shortness of breath and fatigue, which she did not have previously. Concerned about these symptoms, the healthcare team conducts a more detailed examination and orders additional diagnostic tests, including a chest X-ray and an echocardiogram, to rule out potential cardiovascular issues or fluid overload that could be related to the recent antihypertensive therapy. Meanwhile, the patient's white blood cell count remains elevated, hovering around 13,000/mm³, and there is a mild decline in her hemoglobin levels to 10.8 g/dL, indicating a potential underlying inflammatory or infectious process that requires further evaluation.

Given the persistence of gastrointestinal symptoms and the newly emerged respiratory issues, the healthcare team decides to expedite the referral to a gastroenterologist and possibly a pulmonologist, ensuring a comprehensive approach to her evolving condition. The team emphasizes the critical importance of continued monitoring and reassessment, scheduling another follow-up within the week, and maintaining open communication with the patient to adjust her management plan as needed. These steps are essential to ensure both maternal and fetal well-being as her pregnancy progresses.

Section 4

As the healthcare team awaits the results of the chest X-ray and echocardiogram, they focus on addressing the patient's gastrointestinal symptoms, which have persisted alongside her new respiratory complaints. During the initial assessment by the gastroenterologist, the patient reports frequent episodes of constipation, abdominal bloating, and occasional cramping, which have not improved despite dietary modifications and increased fluid intake. Her bowel movements remain infrequent, occurring only every three to four days. Upon examination, mild abdominal distension is noted, with generalized tenderness, particularly in the lower quadrants, but without guarding or rebound tenderness. Her vital signs are stable, with a heart rate of 88 beats per minute and a respiratory rate of 20 breaths per minute, though she still experiences mild dyspnea with exertion.

The newly performed chest X-ray reveals no signs of acute pulmonary edema or significant pleural effusion, but slight cardiomegaly is noted, raising concerns about underlying cardiac stress. The echocardiogram, however, shows normal left ventricular function with an ejection fraction of 60%, suggesting that her shortness of breath is unlikely due to heart failure. Meanwhile, laboratory tests indicate that her elevated white blood cell count remains consistent at 13,200/mm³, and her hemoglobin level is slightly lower at 10.5 g/dL, raising suspicion of an ongoing inflammatory process. The team considers whether her symptoms might be partially attributed to pregnancy-related physiological changes or an undiagnosed underlying condition, such as anemia of chronic disease, which could explain her fatigue and dyspnea.

In response to these findings, the healthcare team decides to adjust the patient's management plan. They introduce a stool softener to alleviate constipation, anticipating potential relief of her abdominal discomfort and bloating. Additionally, they schedule a pulmonary function test to further investigate the cause of her respiratory symptoms, suspecting that mild anemia and constipation-related discomfort might be contributing factors. The patient is advised to continue monitoring her symptoms and maintain regular follow-up appointments to reassess her condition and the effectiveness of the interventions. Through this comprehensive approach, the team aims to ensure both her well-being and the healthy progression of her pregnancy, while remaining vigilant for any new complications.

Section 5

Two weeks after the initial management changes, the patient returns for a follow-up appointment. She reports some improvement in her bowel movements, which are now occurring every other day with the help of the prescribed stool softener. However, she continues to experience abdominal bloating and occasional cramping, though less severe than before. Of more pressing concern, she describes increased episodes of dyspnea, even at rest, along with a new symptom of palpitations. During the physical examination, her vital signs reveal a slight increase in heart rate to 95 beats per minute, and her respiratory rate remains elevated at 22 breaths per minute. Her blood pressure is stable at 118/78 mmHg. On auscultation, her lung sounds are clear, but there is a noticeable irregularity in her heart rhythm.

The results of the pulmonary function test are available and show a mild restrictive pattern, but no significant obstruction. Given the patient's persistent dyspnea and new cardiac symptoms, the healthcare team decides to perform a Holter monitor test to assess for any arrhythmias contributing to her palpitations and shortness of breath. Additionally, they repeat a complete blood count, which now shows a further decline in hemoglobin to 9.8 g/dL, suggesting that her anemia may be progressing. The team considers the possibility of iron deficiency anemia, common in pregnancy, but also remains open to other causes given the chronicity and persistence of her symptoms.

These developments prompt the healthcare team to reconsider the overall management plan. They decide to initiate iron supplementation while awaiting further diagnostic results to address the anemia, which could be exacerbating her cardiac and respiratory symptoms. The patient is educated about the potential side effects of iron supplements and the importance of adherence to improve her overall condition. With these interventions in place, the team continues to monitor her closely, emphasizing the need for regular follow-ups to evaluate her response and adjust the treatment plan as necessary, while remaining vigilant for any new or worsening symptoms.